Search Results 441-450 of 11026 for SC

  1. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  2. Publications - Matthew L. Carlson, M.D. - Mayo Clinic

    ... SC, Golfinos JG, Roland JT, Hunter JB, Kutz JW, Santa Maria PL, Link MJ, Tveiten OV, Carlson ML. Optimal Timing of Primary Radiosurgical Treatment of ...

  3. Internal Medicine Residency (Florida) - Alumni

    University of South Carolina, Greenville, SC. Tanmayi Pai, Hematology/oncology fellowship, Mayo Clinic, Jacksonville, FL. Kamal Shair, Chief Resident in ...

  4. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  5. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  6. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  7. Jim R. Dornhoffer, M.D. - Mayo Clinic Faculty Profiles

    Residency Medical University of South Carolina; Medical School University of Arkansas for Medical Sciences; Undergraduate Studies Hendrix College. src ...

  8. Rheumatoid arthritis - Symptoms and causes - Mayo Clinic

    This ongoing condition can affect more than just the joints. It also can damage skin, eyes, lungs, heart and blood vessels.

  9. A Study of Overhead Body Weight Supported Walk Training in Stroke Patients - Mayo Clinic

    Debra Ness, P.T., D.Sc., NCS. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information.

  10. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free survival ...